To gain insight into the role of BASIGIN in the tumour microenvironment, we genetically disrupted BASIGIN in three human tumour cell lines derived from glioma, colon, and lung adenocarcinoma using zinc finger nuclease (ZFN) technology. This evidence concerns the gene BSG and glioma.